ORIC Pharmaceuticals Inc
(STU:4TZ)
€
9.5
0.3 (3.19%)
Market Cap: 678.15 Mil
Enterprise Value: 413.43 Mil
PE Ratio: 0
PB Ratio: 2.30
GF Score: 41/100 
Oric Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Jun 07, 2023 / 02:00PM GMT
Release Date Price:
€5.25
(+5.00%)
Maury Raycroft
(Trades, Portfolio) - Analyst
Hi. My name is Maury Raycroft and then I'm of the biotech analysts at Jefferies. We're going to do a fireside chat today with ORIC. Got Jacob and Dominic with me. Thanks so much for joining us.
Maybe to start off if you guys want to provide a one-minute intro to ORIC.
Jacob Chacko
ORIC Pharmaceuticals, Inc. - President, CEO & Board Member
Sure. Happy to, Maury. Thanks for having us. So ORIC stands for Overcoming Resistance in Cancer, and that, in a nutshell, is the mission of the company. We are focused on small molecule drug development, and primarily in solid tumors, with one exception that we'll talk about, I'm sure, today.
There's a lot of expertise inside the company based on the team
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers